nirogacestat 150 MG (equivalent to nirogacestat HBr 199.574 MG) Oral Tablet

RxCUI: 2680366
RxNorm name: nirogacestat 150 MG (equivalent to nirogacestat HBr 199.574 MG) Oral Tablet
Display name: nirogacestat 150 MG (equivalent to nirogacestat HBr 199.574 MG) Oral Tablet
Full name: nirogacestat 150 MG (equivalent to nirogacestat HBr 199.574 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OGSIVEO	NIROGACESTAT	SpringWorks Therapeutics, Inc.	f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	2026-03-26	Warnings, Adverse reactions	Exact identifier rxcui: 2680366

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	nirogacestat 150 MG (equivalent to nirogacestat HBr 199.574 MG) Oral Tablet	SY	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	nirogacestat 150 MG Oral Tablet	PSN	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	nirogacestat 150 MG Oral Tablet	SCD	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326